What is the chance of surviving surgery for bile duct cancer

As patients, especially their family members, as long as there is hope for treatment, even if it is very slim, we are unwilling to give up easily. Because people's desire for life and their attachment to their loved ones are urgent and deep, but the treatment effect of some dangerous diseases is not satisfactory. Biliary duct cancer, a very dangerous disease, is very difficult to operate on. Next, let's find out what is the survival rate of bile duct cancer surgery?

Traditionally, the prognosis of cholangiocarcinoma is considered to be extremely poor, which is related to the clinical type, pathological characteristics and treatment methods. The average survival of the surgical resection group is generally 13 months, and it is rare to survive for 5 years. If only internal or external drainage of the bile duct is performed, the average survival is only 6 to 7 months, and rarely exceeds 1 year.

Without any surgery or drainage, most patients with bile duct cancer die within 3 months of diagnosis. The 1-year and 3-year survival rates of patients with more thorough tumor resection are 90% and 40%, respectively, while those with palliative surgery are only 55% and 10%. The survival time of advanced patients with simple drainage rarely exceeds 1 year. Literature reports that the survival time of upper, middle and lower bile duct cancer is (8.75±6.31), (10.31±8.01) and (14.48±12.95) months, respectively. When comparing the prognosis of different treatment methods, surgical resection is the best, which is significantly better than simple jaundice reduction surgery. Therefore, for patients with extrahepatic bile duct cancer who have the conditions, radical resection should be performed as early as possible.

With the development of radical resection, the application of memory alloy biliary stents, and the application of comprehensive post-vertebral treatment measures, the 2-year survival rate after radical resection has reached 40% to 70%, the average survival time after palliative treatment has exceeded 1 year, and the patient's quality of life has also improved, but the 5-year survival rate is still low.

Other data show that scientific symptomatic treatment methods can increase the three-year survival rate of patients with early and middle-stage bile duct cancer from 22% to 76%. Only early detection and early treatment can achieve satisfactory treatment results.